India proposes price regulation for patented drugs

02/27/2013 | Economic Times (India), The

A government panel in India has recommended that prices for expensive drugs to treat critical diseases like HIV, cancer and hepatitis be based on the nation's per capita income, which could substantially reduce their costs and make them more affordable for patients. Some in the industry warn, however, that the regulations could backfire and instead prevent companies from offering new drugs in India.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD